Skip to main content

Table 2 Clinical outcomes and postoperative complications after HAAM implantation surgery

From: Human acellular amniotic membrane implantation for lower third nasal reconstruction: a promising therapy to promote wound healing

Variable HAAM group Control group P value
Haemostasis time (min, mean ± SD) 3.11 ± 1.14 5.48 ± 1.53 < 0.001
Disappearance time of pain (hour, mean ± SD) 6.36 ± 1.90 11.11 ± 3.55 < 0.001
Time of scab formation (day, mean ± SD) 4.75 ± 1.13 6.84 ± 1.07 < 0.001
Time of scab detachment (day, mean ± SD) 6.70 ± 0.98 8.72 ± 1.99 < 0.001
Healing rate (mm, mean ± SD)
 0–5 mm 3.54 ± 0.88 3.29 ± 0.69 0.30
 5–10 mm 6.79 ± 1.25 5.26 ± 0.97 < 0.001
 > 10 mm 10.27 ± 1.62 8.45 ± 0.93 < 0.05
Bleeding (n) 2 7 < 0.001
Wound infection (n) 4 14 < 0.05
Scar (n) 4 12 < 0.05
  1. HAAM human acellular amniotic membrane, SD standard deviation